HerbertLoydBonkovskyMD

Hepatology & Liver Transplantation, Nutrition, Clinical Pharmacology

Professor of Medicine and Molecular Medicine & Translational Sciences; Chief of Porphyria Clinics, and Laboratory for Liver and Metabolic Disorders

Join to view full profile

Dr. Bonkovsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bonkovsky's full profile

Already have an account?

Office
1 S Hawthorne Rd
Winston Salem, NC 27157
Phone+1 336-713-7306

Summary

Dr. Herbert Bonkovsky is a gastroenterologist and hepatologist precticing at Wake Forest Baptist Medical Center in Winston Salem, NC. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 53 years. He specializes in hepatology & liver transplantation, nutrition, and pancreas disease. He has particular expertise in metabolic disorders such as the porphyrias, hemochromatosis, Wilson's disease, aceruloplasminemia, and drug-induced liver injury. He has long experience in general hepatology and gastroenterology, cirrhosis and its complications, and viral hepatitides.

Clinical Expertise

Hepatology, iron disorders, porph, Hepat, Hepatic cirrhosis, General gastroenterology, Biliary tract disease, Esophageal disease, Malabsorptive disorders, Viral hepatitides, Drug-induced hepatitis, Porphyrias, Inherited disorders of copper metabolism, Hemochromatosis, Porphyria cutanea tarda, Infection-induced thrombocytopenia, Liver cirrhosis, Biopsies, Liver transplantation, Severity of illness index, Hepatic cancer, Transplant hepatology, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hepatitis C, Hepatitis B, Cirrhosis due to chronic viral hepatitis, Gastrointestinal / Hepatic pathology, Hepatocellular carcinoma

Education & Training

Yale-New Haven Medical CenterFellowship, Transplant Hepatology, 1973 - 1974
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1971 - 1973
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1968 - 1969
Duke University HospitalInternship, Internal Medicine, 1967 - 1968
Case Western Reserve University School of MedicineClass of 1967
Earlham CollegeA.B.

Certifications & Licensure

NC State Medical License 2008 - 2024
CT State Medical License 1999 - 2009
MA State Medical License 1990 - 2002
GA State Medical License 1985 - 1991
OH State Medical License 1968 - 1976
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Emeritus Member, American Society for Clinical Investigation ASCI
Fellow AGA
Fellow AASLD
Elected Member Association of American Physicians
Recipient of Governors Award for Excellence in Clinical Research ACG, 2014
Elected to Fellowship AGA, 2014
Elected to Fellowship AASLD, 2014
Selected as one of the Leading Physicians of the World Intl Assoc of Healthcare Professionals, 2013
Finalist, Excellence in Health Care Awards Intl Assoc of Healthcare Professionals, 2013
Winner of Elsevier Research Initiative Award AGA Foundation for Digestive Health and Nutrition, 2006
Outstanding Alumnus Earlham College, 2004
Elected to America’s Registry of Outstanding Professionals 2003
Finalist Palmer “Courage to Teach” Award The American Council for Graduate Medical Education’s, 2001
Nominated as an International Man of the Year International Biographical Centre (IBC), 2001
Recipient of 21st Century Award for Achievement International Biographical Centre (IBC), 2001
Gold Record of Achievement American Biographical Institute, 2001
Selected as one of the Outstanding Intellectuals of the 21st Century International Biographical Centre (IBC), 2001
Selected as one of the Outstanding Scientists of the 20th Century International Biographical Centre (IBC), 2000
Elected Association of American Physicians, 1998
Who’s Who in the World 1998
Selected by peers as one of the Best Doctors in America 1995
Who’s Who in the Northeast 1990
Who’s Who in Science and Technology 1990
Who’s Who in the U.S.A. 1990
Elected The American Society of Clinical Investigation, 1987
Elected Member The American Society for Clinical Investigation, 1981
"Golden Apple" (Teacher-of-the-Year) Runner-up Department of Medicine, Dartmouth-Hitchcock Medical Center, 1976
Borden Award for excellence in research as a medical student Case Western Reserve Univ. School of Medicine, 1967
Alpha Omega Alpha Case Western Reserve Univ. School of Medicine, 1966
Mosby Award for scholastic excellence Case Western Reserve Univ. School of Medicine, 1963
Binz Memorial Scholar Case Western Reserve Univ. School of Medicine, 1963
Merit Scholar Earlham College
Departmental honors in Chemistry Earlham College
Fellow (FACG) American College of Gastroenterology
Join now to see all

Clinical Trials

Longitudinal Study of the Porphyrias Start of enrollment: 2010 Nov 01
Recruiting
Clinical Diagnosis of Acute Porphyria Start of enrollment: 2011 Dec 01
Completed
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact Start of enrollment: 2012 Jul 01
Completed
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)) Start of enrollment: 2011 Nov 01
Completed
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) Start of enrollment: 2014 Aug 01
Completed
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Start of enrollment: 2016 Nov 29
Completed
Phase 2
Harvoni Treatment Porphyria Cutanea Tarda Start of enrollment: 2017 Sep 06
Completed
Phase 2
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) Start of enrollment: 2017 Nov 16
Completed
Phase 3
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria Start of enrollment: 2018 Jul 05
Completed
Phase 2
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria Start of enrollment: 2019 Apr 03
Completed
Multicentre Phase III Erythropoietic Protoporphyria Study Start of enrollment: 2007 May 01
Completed
Phase 3
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
Approved for marketing
Join now to see all

Publications & Presentations

PubMed

42 citations
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Anna S. Lok, James E. Everhart, Raymong T. Chung, Hae-Young Kim, Gregory T. Everson
Hepatology. 2009-06-01
86 citations
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.
Hellen A. Oketch-Rabah, Amy L. Roe, Cynthia V. Rider, Herbert L. Bonkovsky, Gabriel I. Giancaspro
Toxicology Reports. 2020-02-15
582 citations
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy J. Davern
Gastroenterology. 2008-12-01

Journal Articles

Features of autoimmunnune hepatitis in patients with drug-induced liver injury
de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH for the Drug-Induced Liver Injury Network, Gastroenterol Hepatol, 1/13/2016
Cimetidine for EPP?
Balwani M, Anderson KE, Desnick RJ, on behalf of the NIH-supported Porphyrias Consortium of the Rare Diseases Clinical Research Network Investigators, JAMA Dermatology, 1/1/2016
Febuxostatinduced acute liver injury
Bohm M, Vuppalanchi R, Chalasani N, Drug-Induced Liver Injury Network, Hepatology, 1/1/2016
Azathioprine and 6-mercaptopurine induced liver injury: clinical features and outcomes
Bjornsson ES, Gu J, Kleiner DE, Chalasani N, Hayashi PH, Hoofnagle JH for the DILIN Investigators, J Clin Gastroenterol, 1/1/2016
Severe acute hepatocellular injury attributed to OxyELITE Pro
Heidemann LA, Navarro VJ, Ahmad J, Hayashi PH, Stolz A, Kleiner DE, Fontana RJ, on behalf of the DILIN Investigators, Dig Dis Sci, 1/1/2016
Risk of liver injury associated with green tea extract in SLIMQUICK weight loss products: results from the DILIN prospective study
Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, Navarro VJ for the Drug Induced Liver Injury Network (DILIN), Drug Saf, 1/1/2016
Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury
Suzuki A, Gu J, Barnhart H, Bonkovsky HL, Tillmann HL, Fontana RJ, Kleiner DE, for the US DILIN Investigators, Liv Intl, 1/1/2016
Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury
Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, Lee WM, Stolz A, Serrano J, Watkins PB, for the DILIN investigators, Amer J Gastroent, 1/1/2015
The day dapsone DRESSed as DILI
Sigmon LB, Roche TD, Bonkovsky HL, J Clin Toxicol, 1/1/2015
Liver injury from nonsteroidal antiinflammatory drugs in the United States
Schmeltzer PA, Kosinski AS, Kleiner DE, Hoofnagle JH, Stolz A, Fontana RJ, lRusso MW, for the Drug-Induced Liver Injury Network (DILIN), Liver Intl, 1/1/2015
Hepatotoxicity of anti-TNF agents
Bonacini M, Ghabril M, Bonkovsky HL, Dig Dis Sci, 1/1/2014
Idiosyncratic drug induced liver injury is associated with substantial morbidity and mortality within six months of onset
Fontana RJ, HayashiPH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwalkar JA, on behalf of the DILIN Network, Gastroenterology, 1/1/2014
Herbal and dietary supplement hepatotoxicity
Maddukuri VC, Bonkovsky HL, Clinical Liver Disease, 1/1/2014
Risk factors for porphyria cutanea tarda—the iron/HFE connection
Bonkovsky HL, Liver International, 1/1/2013
Review –Statins and liver injury
Thapar M, Russo MW, Bonkovsky HL, Gastroenterology & Hepatology, 1/1/2013
Clinical Decision Support: Gastroenterology and Hepatology
Caballes FR, Bonkovsky HL, 1/1/2013
International Review of Cell and Molecular Biology
Ghosh S, Kaplan KJ, Schrum LW, Bonkovsky HL, 1/1/2013
Cefazolin induced liver injury: an under-recognized disorder
Alqahtani SA, Kleiner DE, Ghabril M, Gu, J, Hoofnagle JH, Rockey DC, for the DILIN Study Investigators, Clin Gastro Hepatol, 1/1/2013
Zakim and Boyer’s Hepatology—a Textbook of Liver Disease
Bonkovsky HL, Shedlofsky SI, Jones DP, and Russo M, 1/1/2012
The role of iron in hepatitis C infection
Desai T, Bortman J, Al-Sibae R, Bonkovsky HL, Current Hepatitis Reports, 1/1/2012
Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis
Corey KE, Zheng H, Mendez-Navarro J, Delgado-Borrego A, Dienstag JL, Chung RT; HALT-C Trial Group, PLoS One, 1/1/2012
Medical food and food supplements: not always as safe as generally assumed
Chalasani N, Vuppalanchi R, , Navarro V, Fontana RJ, Bonkovsky HL, Barnhart H, Kleiner DE, Hoofnagle JH, on behalf of the US Drug-induced Liver Injury Network, Ann Intern Med156, 1/1/2012
Reduction in hepatic inflammation is associated with less fibrosis progression and fewer clinical outcomes in advanced hepatitis C
Morishima C, Shiffman ML, Dienstag JL, Lindsay KL, Szabo G, Everson GT, Lok AS, Di Bisceglie AM, Ghany MG, Naishadham D, Morgan TR, Wright EC, for the HALT-C Trial Group, Am J Gastroenterol, 1/1/2012
Invited Commentary on Deugnier et al Improvement in liver pathology of patients with B-thalassemia treated with deferasirox for at least three years
Bonkovsky HL, GI & Hepatology News Highlights, 1/1/2011
Amyotrophic Lateral Sclerosis
Panov A, Steuerwald N, Vavilin V, Dambinova S, Bonkovsky HL, 1/1/2011
Join now to see all

Books/Book Chapters

Encyclopedia of Life Sciences
Besur S, Bonkovsky HLJohn Wiley & Sons, Ltd, Chichester, England2015
Comprehensive Physiology
Chapter: Porphyrin and heme metabolism and the porphyrias
Bonkovsky HL, Hou W, Li T, Guo J-T, Narang T, Thapar MEditors: Wolkoff A, Lu S, and Omary B.The American Physiological Society, Wiley and Co, Bethesda, MD2013
Hepatology: A Textbook of Liver Disease
Chapter: Porphyrin and heme metabolism and the porphyrias
Page 378 - 424Bonkovsky HLEditors: D. Zakim and T. Boyer.Saunders, Philadelphia, PAEdition 2nd,1990
Criteria for Diagnosis
Chapter: Granulomatous hepatitis and hepatic granulomas
Page 460 - 462Bonkovsky HLEditors: J.W. Hurst.Butterworth's, Boston, MA1989
Medicine for the Practicing Physician
Chapter: Granulomatous Hepatitis and Hepatic Granulomas
Page 1313 - 1316Bonkovsky HLEditors: J.W. Hurst.Butterworth's, London, UKEdition 2nd,1988
Hexachlorobenzene: Proceedings of an International Symposium
Chapter: Induction of porphyria in cultured chick embryo hepatocytes by halogenated aromatic compounds
Page 535 - 542Sinclair PR, Sinclair JF, Bement WJ, Lambrecht RW, and Bonkovsky HLEditors: C.R. Morris and J.R.P. Cabrial.IARC Scientific Publication, Lyon, France1986
Porphyrins and Porphyrias
Chapter: Induction of deltaaminolevulinate synthase and changes in porphyrin patterns caused by 2- to 5-carbon alcohols: Possible risk factors in patients with hepatic porphyrias
Page 137 - 146Sinclair JF, Zaitlin LM, Smith EL, Howell S, Bonkovsky HL and Sinclair PREditors: Y. Nordmann.J. Libbey, London, UK1986
Current Diagnosis
Chapter: The Porphyrias
Page 799 - 809Bonkovsky HLEditors: R.B. Conn.Saunders, Philadelphia, PA1985
Alcohol Use and Its Medical Consequences
Chapter: Alcohol: Pregnancy and the Fetal Alcohol Syndrome
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Alcohol Use and Its Medical Consequences
Chapter: Endocrine and Metabolic Effects of Alcohol
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Alcohol Use and Its Medical Consequences
Chapter: The Neurological Complications of Alcohol and Alcoholism
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Alcohol Use and Its Medical Consequences
Chapter: Alcohol: The Alimentary Tract and Pancreas
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Alcohol Use and Its Medical Consequences
Chapter: Hematologic Complications of Alcohol Use
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Alcohol Use and Its Medical Consequences
Chapter: Alcohol and the Liver
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Alcohol Use and Its Medical Consequences
Chapter: Biochemistry, Pharmacology and Toxicology of the Alcohols
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1983
Connective Tissue of the Normal and Fibrotic Human Liver - Present State of Biochemistry, Clinical Evaluation and Treatment
Chapter: Different effect of iron and ethanol on collagenase production by fibroblasts
Page 65 - 66Okazaki I, Brinckerhoff CE, Sinclair JF, Sinclair PR, Bonkovsky HL and Harris ED, JrEditors: Gerlach U., Pott G., Rauterberg J & Voss B.Georg Thieme Verlag, Stuttgart, Germany1982
Unit 4 of "Alcohol Use and Its Medical Consequences"
Chapter: Alcohol: The Alimentary Tract and Pancreas
Anderson PB and Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1982
Porphyrin and heme metabolism and the porphyrias
Chapter: Hepatology: A Textbook of Liver Disease
Page 351 - 393Bonkovsky HLEditors: D. Zakim and T. Boyer.Saunders, Philadelphia, PA1982
Unit 4 of "Alcohol Use and Its Medical Consequences"
Chapter: Alcohol and the Liver
Bonkovsky HLThe Alcohol Slide/Teaching Library, Operation Cork1981
Kinetics of hepatic heme turnover in rats given allylisopropylacetamide: a new model for liver heme catabolism, in Microsomes, Drug Oxidations, and Chemical Carcinogenesis
Page 571 - 574Bonkovsky H, Sinclair P, Healey J, Sinclair JEditors: Coon, M.J., Conney, A.H., Estabrook, R.W., Gelboin, H.V., Gillette, J.R., O'Brien, P.J..Academic Press, New York, NY1980
Coincident induction of cytochromes P450 and phenol red conjugation in cultured chick embryo hepatocytes; effects of cobaltous and manganous ions, in Microsomes, Drug Oxidations, and Chemical Carcinogenesis
Page 893 - 896Sinclair P, Sinclair J, Bement J, Farnham A, Pomeroy J and Bonkovsky HEditors: Coon, M.J., Conney, A.H., Estabrook, R.W., Gelboin, H.V., Gillette, J.R., O'Brien, P.J..Academic Press, New York, NY1980
Chronic Disease Algorithms
Bonkovsky HL, Kaplan AD, Sox HC Jr., Tompkins RK and Sox CHDartmouth Medical School PROMIS Laboratory, Hanover, NH1974
Join now to see all

Abstracts/Posters

Vascular reactivity in mesenteric arteries from a rodent model of acute intermittent porphyria [AIP]
Pulgar VM, Ademoyero OT, Aileru AA, Yasuda M, Gan L, Desnick RJ, Bonkovsky HL, Gordon Research Conference on Tetrapyrroles, 50th Anniversary, Salve Regina University, Newport, RI, 1/22/2016
A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks
Anderson KE, Balwani M, Ventura P, Ivanova A, Bloomer JR, Bissell DM, Stölzel U, Parker C, Rees D, Stein P, Windyga J, Kaupinnen R, Langendonk J, Badminton M, Minder E..., 67th Annual Meeting of American Association for the Study of Liver Diseases, Boston, MA, 1/14/2016
Serum IgM autoantibody profiling using autoantigen arrays identifies histone H4 IgM antibody as highly specific to patients with autoimmune like drug induced liver injury
Chalasani N, Xu Y, deBoer Y, Raman I, Lian Y, Eckert G, Li Q, Hoofnagle J, for the DrugInduced Liver Injury Network, 67th Annual Meeting of American Association for the Study of Liver Diseases, Boston, MA, 1/14/2016
Idiosyncratic drug induced liver injury in African Americans: causes, clinical features, and outcomes
Chalasani N, Ghabril M, Fontana RJ, Barnhart H, Hayashi P, Ahmad J, Stolz A, Navarro V, Hoofnagle JH, for the Drug Induced Liver Injury Network (DILIN), 67th Annual Meeting of American Association for the Study of Liver Diseases, Boston, MA, 1/14/2016
A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks
Anderson KE, Balwani M, Ventura P, Ivanova A, Bloomer JR, Bissell DM, Stölzel U, Parker C, Rees D, Stein P, Windyga J, Kaupinnen R, Langendonk J, Badminton M, Minder E..., Hepatology, 1/1/2016
Serum IgM autoantibody profiling using autoantigen arrays identifies histone H4 IgM antibody as highly specific to patients with autoimmune like drug induced liver injury
Chalasani N, Xu Y, deBoer Y, Raman I, Lian Y, Eckert G, Li Q, Hoofnagle J, for the DrugInduced Liver Injury Network, Hepatology, 1/1/2016
Idiosyncratic drug induced liver injury in African Americans: causes, clinical features, and outcomes
Chalasani N, Ghabril M, Fontana RJ, Barnhart H, Hayashi P, Ahmad J, Stolz A, Navarro V, Hoofnagle JH, for the Drug Induced Liver Injury Network (DILIN), Hepatology, 1/1/2016
Anabolic steroid jaundice: 44 cases
Stolz A, Navarro V, Hayashi P, Chalasani N, Fontana RJ, Bonkovsky HL, Hoofnagle JH, Kleiner DE, Barnhart H, for the DILIN Investigators, NIH-AASLD-FDA Conference on Drug-Induced Liver Injury due to Herbals and Dietary Supplements; 66th Annual Meeting of American Association for the Study of Liver Diseases, Lister Hill Auditorium, NIH, Bethesda, MD, 2015; San Francisco, CA, 2015, 1/17/2015
The clinical-pathological spectrum and outcomes of liver injury due to drugs and botanicals associated with loss of bile ducts
Bonkovsky HL, Kleiner DE, Gu J, Odin JA, Russo MW, Navarro VM, Vega M, Hoofnagle JH, for US Drug-induced Liver Injury Network Investigators, 66th Annual Meeting of American Association for the Study of Liver Diseases, San Francisco, CA, 1/17/2015
Pitfalls in measurement of erythrocyte protoporphyrin for diagnosis of erythropoietic protoporphyria and X-linked protoporphyria
Gou E, Balwani M, Bissell DM, Bloomer JR, Bonkovsky HL, Desnick RJ, Naik H, Phillips JD, Singal AK, Anderson KE, 66th Annual Meeting of American Association for the Study of Liver Diseases, San Francisco, CA, 1/17/2015
Variability in erythrocyte and plasma porphyrin levels in erythropoietic protoporphyria and X-linked protoporphyria
Gou E, Balwani M, Bissell DM, Bloomer JR, Bonkovsky HL, Desnick RJ, Naik H, Phillips JD, Singal AK, Anderson KE, 66th Annual Meeting of American Association for the Study of Liver Diseases, San Francisco, CA, 1/17/2015
Anabolic steroid jaundice: 44 cases
Stolz A, Navarro V, Hayashi P, Chalasani N, Fontana RJ, Bonkovsky HL, Hoofnagle JH, Kleiner DE, Barnhart H, for the DILIN Investigators, Hepatology, 1/1/2015
The clinical-pathological spectrum and outcomes of liver injury due to drugs and botanicals associated with loss of bile ducts
Bonkovsky HL, Kleiner DE, Gu J, Odin JA, Russo MW, Navarro VM, Vega M, Hoofnagle JH, for US Drug-induced Liver Injury Network Investigators, Hepatology, 1/1/2015
Pitfalls in measurement of erythrocyte protoporphyrin for diagnosis of erythropoietic protoporphyria and X-linked protoporphyria
Gou E, Balwani M, Bissell DM, Bloomer JR, Bonkovsky HL, Desnick RJ, Naik H, Phillips JD, Singal AK, Anderson KE, Hepatology, 1/1/2015
Variability in erythrocyte and plasma porphyrin levels in erythropoietic protoporphyria and X-linked protoporphyria
Gou E, Balwani M, Bissell DM, Bloomer JR, Bonkovsky HL, Desnick RJ, Naik H, Phillips JD, Singal AK, Anderson KE, Hepatology, 1/1/2015
Phase III trial of afamelanotide 16 mg subcutaneous bioresorbable implants for the treatment of erythropoietic protoporphyria
Desnick RJ, Anderson KE, Bissell DM, Bloomer JE, Bonkovsky HL, Lebwohl M, Lim H, Parker C, Phillips J, Naik H, Balwani M., 64th Annual Meeting of the American Society of Human Genetics, San Diego, CA, 1/23/2014
Idiosyncratic drug-induced liver injury in the United States: a report of 1257 prospectively enrolled patients
Chalasani N, Bonkovsky HL, Fontana RJ, Lee WM, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu X, Serrano J, for the US Drug-Induced Liver Injury..., Annual Meeting of American College of Gastroenterology, Philadelphia, PA, 1/22/2014
Homeostasis of iron and hepcidin in erythropoietic protoporphyria and X-linked protoporphyria
Bossi K, Lee J, Schmeltzer, Holburton E, Groseclose G, Besur S, Hwang S, Bonkovsky HL, Annual Meeting of American College of Gastroenterology, Philadelphia, PA, 1/22/2014
Idiosyncratic drug-induced liver injury in the United States: a report of 1257 prospectively enrolled patients
Chalasani N, Bonkovsky HL, Fontana RJ, Lee WM, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Hoofnagle JH, for the US Drug-Induced Liver Inj..., 79th Annual Meeting of American College of Gastroenterology, Philadelphia, PA, 1/22/2014
Drug-induced liver injury (DILI) in patients with underlying liver disease has worse prognosis: results from the Drug-Induced Liver Injujry Network (DILIN) prospective...
Chalasani N, Bonkovsky HL, Fontana RJ, Gu J, Hayashi P, Stolz A, Lee WM, Navarro V, Barnhart H, Hoofnagle JH, for the US Drug-Induced Liver Injury Network, 79th Annual Meeting of American College of Gastroenterology, Philadelphia, PA, 1/22/2014
Variability in erythrocyte and plasma porphyrin levels in erythropoietic protoporphyria and X-linked protoporphyria
Guo E, Phillips J, Balwani M, Bissell DM, Bloomer JR, Bonkovsky HL, Desnick RJ, Naik H, Anderson KE, 79th Annual Meeting of American College of Gastroenterology, Philadelphia, PA, 1/22/2014
Amoxicillin-clavulanate induced drug-induced liver injury (DILI): analysis of 113 cases studied prospectively by the US Durg-Induced Liver Injury Network (DILIN)
deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart H, Russo MW, Bonkovsky HL, for the US DILIN Investigators, Annual Meeting of AASLD, Washington, DC, 1/11/2014
Profiles of serum microRNAs in acute drug-induced liver injury and their prognostic significance
Russo MW, Norton HJ, Anderson W, Steuerwald N, Barnhart H, Chalasani N, Fontana RJ, Hayashi PK, Serrano J, Bonkovsky HL, Annual Meeting of AASLD, Washington, DC, 1/11/2014
Variability in erythrocyte and plasma porphyrin levels in erytrhopoietic protoporphyria and X-linked protoporphyria
Gou E, Phillips J, Balwani M, Bissell DM, Bloomer JR, Bonkovsky HL, Desnick RJ, Naik H, Anderson KE, 65th Annual Meeting of American Association for the Study of Liver Diseases, Boston, MA, 1/11/2014
Development of novel biomarker for early detection of pancreatic cancer
Ghosh S, Brenan MP, Ahrens W, Jacobs C, Iannitti D, Martinie J, Swan R, Bonkovsky HL, Annual Meeting of American Society of Cell Biology, Philadelphia, PA, 1/10/2014
Join now to see all

Lectures

Liver injury due to anti-TNF agents and other biologics
Hyattsville, MD - 1/24/2016
Drug-Induced Liver Injury—Perspectives from the USA and the Drug-Induced Liver Injury Network
Beijing, PR China, 2016; Winston-Salem, NC, 2016 - 1/20/2016
Diabetes, Obesity and Metabolism
Winston-Salem, NC - 1/17/2016
Porphyrias—Update on Pathogenesis, Diagnosis, and Management
New Orleans, LA - 1/27/2015
Clinical Features and Pathogenesis of the Acute Porphyrias
Galveston, TX - 1/2/2015
Porphyria 101 for Gastroenterologists
Winston-Salem, NC - 1/9/2014
Update on the Porphyrias, with emphasis on hepatic aspects
Philadelphia, PA - 1/11/2013
Porphyrins and Porphyrias
Cardiff, Wales, UK - 1/11/2011
Science and Religion
Charlotte, NC - 1/2/2011
Drug-Induced Liver Injury
Atlanta, GA - 1/1/2005
Co-Morbid Factors in Chronic Hepatitis C
Chicago, IL - 1/1/2002
Non-alcoholic Fatty Liver Disease
Boston, MA - 1/1/2002
Non-invasive Measures of Body Iron
Bethesda, MD - 1/1/2001
Trends in Management of GI Disorders
Shrewsbury, MA - 1/1/2000
Contemporary Issues in Liver Transplantation
Shrewsbury, MA - 1/1/2000
Non-alcoholic Steatohepatitis
Bethesda, MD - 1/1/1998
Porphyrin and Heme Metabolism
Yonago City, Japan - 1/1/1998
Chronic Hepatitis C
Bethesda, MD - 1/1/1997
Chronic Viral Hepatitis
Kaoshiung, Taiwan - 1/1/1996
Pyrroles
Wolfeboro, NH - 1/1/1994
Transfusion Medicine
Worcester, MA - 1/1/1993
Hemochromatosis
Multiple Locations, 1989, 1991, 1998 - 1/1/1991
Proteins of Iron Metabolism
Brisbane, Queensland, Australia - 1/1/1989
Iron-Storage Diseases
Chicago, IL - 1/1/1987
Mechanisms of Chemical-Induced Porphyrinopathies
Ryebrook, NY - 1/1/1986
Join now to see all

Other

Treatment of chronic hepatitis C: predictors and results. In "Chronic Hepatitis C" Krawitt EL (ed.), Clinical Advances in Gastroenterology
Bonkovsky HL, Educational Reviews, Inc.
Birmingham, AL - 1/1/1995